Incorporated in 1973, Alkem Labs is leading India based pharmaceutical company engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.
Alkem Labs produces branded generics, generic drugs, active pharmaceutical ingredients and neutraceuticals, which they market in India and 55 countries internationally, primarily the United States.
Company's pharmaceutical business is organized into domestic and international operations. Alkem Labs has a portfolio of over 736 brands in India. Company's most significant therapeutic areas in domestic market are anti-infectives, gastro-intestinal, pain and analgesics, and vitamins, minerals and nutrients.
Alkem Labs have a total of 16 manufacturing facilities: 14 manufacturing facilities at five locations in India and two in the United States. Company have four research and development facilities, two in India and two in the United States. As of June 30, 2015, company employed 483 scientists in research and development functions.
1. Alkem Labs is 5th largest pharmaceutical company in India in terms of domestic sales.
2. Alkem Labs products are also sold in 56 countries. In the United States, company has filed 66 abbreviated new drug applications.
3. Company sells a range of high-quality, cost effective generic drugs to major drug chains, pharmaceutical retailers, wholesalers, food and grocery stores, distributors and managed care companies in the United States.
Alkem Labs has 23 Promoters who jointly hold 64,302,440 Equity Shares of the Company which, in aggregate, constitutes 53.8% of the issued and paid-up Equity Share capital of our Company.
|Particulars||For the year/period ended (in Rs. Million)|
|31 Mar 15||31 Mar 14||31 Mar 13||31 Mar 12|
|Profit After Tax (PAT)||4,370.90||4,402.00||4,667.80||4,318.10|
The objects of the Offer are:
1. To achieve the benefits of listing the Equity Shares on the Stock Exchanges and
2. For the sale of 12,853,442 Equity Shares by the Selling Shareholders.
|Issue Open||Dec 8, 2015 - Dec 10, 2015|
|Issue Type||Book Built Issue IPO|
|Issue Size||12,853,442 Eq Shares of Rs 2 |
(aggregating up to Rs 1,349.61 Cr)
|Face Value||Rs 2 Per Equity Share|
|Issue Price||Rs 1020 - Rs 1050 Per Equity Share|
|Market Lot||14 Shares|
|Min Order Quantity||14 Shares|
|Listing At||BSE, NSE|
No. of Times Issue Subscribed (BSE + NSE)
As on Date & Time
Dec 10, 2015 23:15
Vote Here ...
Sorry, we couldn't find any reviews, please check back later.
Alkem Laboratories Limited
Senapati Bapat Marg,
Lower Parel, Mumbai 400 013
Phone: +91 22 3982 9999
Guaranteed Save 60% to 90% Brokerage
You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.
We can help you choosing the right broker. Contact us today...
Current IPOIPO Dashboard Current Mainline IPO Current SME IPO IPO Calendar Performance Tracker DRHP / RHP Docs
Live IPO InformationIPO Subscription IPO Listing Date IPO Allotment Status IPO Reviews IPO Rating Basis of Allotment
Stock Broker ComparisonCompare Share Brokers Side-by-Side Comparison List of Stock Brokers Broker Complaints Monitor Articles / Tutorials Glossary
Discount Brokers5paisa (Flat ₹10) Zerodha (Flat ₹20) ProStocks (Flat ₹15) Upstox RKSV (Flat ₹20) Trade Smart Online More Discount Brokers >>
Full-service BrokersICICI Direct Motilal Oswal Angel Broking Edelweiss Broking Aditya Birla Money More Full-service Brokers >>
More About BrokersSpecial Offers Broker Reports Top 10 Discount Brokers Top 10 Full-Service Brokers Top 20 Share Brokers
History of ChittorgarhHistory of Chittorgarh Maharana Pratap Meera Bai Panna Dhai Rani Padmini Jainism & Chittor (Hindi)